Harvard Law Review: Patents on Psychedelics: The Next Legal Battlefront of Drug Development
Cannabis Law Report
FEBRUARY 28, 2022
This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. 640, 640 (2011). 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. See Rachel Quibell et al., Ketamine , 41 J. Mitchell et al.,
Let's personalize your content